Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi lifts profit outlook as Dupixent sales surge 43%
Reuters
Fri, 07/29/22 - 09:51 am
Tags:
Sanofi, earnings
Sanofi CEO Paul Hudson says his company is the Big Pharma 'least exposed' to generics this decade
Fierce Pharma
Thu, 07/28/22 - 12:23 pm
Tags:
Sanofi, Paul Hudson, Pharma CEOs, generics
Sanofi rolls out new diversity program to hire Howard University grads
Fierce Biotech
Tue, 07/26/22 - 11:02 am
Tags:
Sanofi, racial diversity, diversity
Low-profile startup stakes its claim to Sanofi's siRNA platform in wake of setbacks
Endpoints
Mon, 07/25/22 - 10:37 am
Tags:
siRNA, China, Sanofi, Rona Therapeutics
Sanofi walks away from kidney disease therapy, leaving $25M in milestones out of reach for Regulus
Fierce Biotech
Tue, 07/19/22 - 10:21 am
Tags:
Sanofi, kidney disease, Regulus, lademirsen
Regeneron, Sanofi Look to Extend Dupixent into Young Kids with Eosinophilic Esophagitis
BioSpace
Thu, 07/14/22 - 11:49 am
Tags:
Regeneron, Sanofi, Dupixent, pediatric, eosinophilic esophagitis
Sanofi offloads 17 brands to Neuraxpharm
Fierce Pharma
Tue, 07/12/22 - 10:57 am
Tags:
Sanofi, CNS, Neuraxpharm
Sanofi jumpstarts effort to supply 30 'essential' drugs to lower-income countries
Endpoints
Tue, 07/5/22 - 11:47 pm
Tags:
Sanofi, philanthropy
Regeneron completes acquisition of Sanofi’s stake in Libtayo
Pharmaceutical Business Review
Mon, 07/4/22 - 11:58 pm
Tags:
Regeneron, Sanofi, Libtayo, cancer
FDA Partially Halts Sanofi’s BTK Inhibitor for Multiple Sclerosis, Myasthenia Gravis
Pharma Live
Thu, 06/30/22 - 10:59 am
Tags:
Sanofi, multiple sclerosis, myasthenia gravis, FDA, tolebrutinib, clinical trials, clinical hold
With Congress weighing insulin cost cap, Sanofi slashes price for uninsured in US
Fierce Pharma
Wed, 06/29/22 - 05:24 pm
Tags:
Sanofi, insulin, drug pricing, diabetes
Two for two: Sanofi snares twin European nods for enzyme replacement therapies
MedCity News
Tue, 06/28/22 - 05:42 pm
Tags:
Sanofi, Europe, Xenpozyme, Nexviazyme, enzyme replacement
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Motley Fool
Mon, 06/27/22 - 10:12 am
Tags:
Sanofi, Regeneron, FDA, Dupixent, eosinophilic esophagitis
Sanofi, GSK tout 72% Omicron efficacy in PhIII trial of next-gen, bivalent shot — with an eye to year-end rollout
Endpoints
Fri, 06/24/22 - 10:56 am
Tags:
Sanofi, GSK, COVID-19, COVID-19 variants, clinical trials, vaccines
CDC's ACIP recommends higher dose, Seqirus, Sanofi flu vaccines in adults 65 and older
Endpoints
Thu, 06/23/22 - 07:55 pm
Tags:
CDC, ACIP, vaccines, Seqirus, Sanofi, flu vaccines, Fluad, Fluzone, FluBlok
Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern
Yahoo/Benzinga
Mon, 06/13/22 - 10:32 am
Tags:
Sanofi, GSK, vaccines, COVID-19, COVID-19 variants, clinical trials
Sanofi union members set strike date in Korea as wage negotiations stall: report
Fierce Pharma
Sun, 06/12/22 - 08:20 pm
Tags:
Sanofi, South Korea, strike, unions
Following tie-up with Sanofi, transatlantic AI firm secures latest Big Pharma deal in nine-figure Bristol Myers pact
Endpoints
Wed, 06/8/22 - 11:07 pm
Tags:
Owkin, artificial intelligence, Sanofi, Bristol Myers Squibb
FDA approves Sanofi and Regeneron’s Dupixent for atopic dermatitis in young children
Pharmaceutical Business Review
Wed, 06/8/22 - 10:44 am
Tags:
Sanofi, Regeneron, FDA, pediatric, atopic dermatitis, Dupixent
Sanofi and Immunocore Pair High Potential Molecules for Metastatic Skin Cancers
BioSpace
Sun, 06/5/22 - 11:31 pm
Tags:
Immunocore, Sanofi, clinical trials, SAR444245, skin cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.